Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells

Abstract

Background Acquired resistance remains a limitation of the clinical use of 5-fluorouracil (5-FU). Because exosomes, are important vesicles participating in intercellular communication, their contribution to the development of acquired 5-FU resistance needs to be elucidated. In this study, we aimed to examine the underlying mechanisms of exosomes from 5-FU resistant cells (RKO/R) in sustaining acquired 5-FU resistance in sensitive cells (RKO/P). Methods Exosomes from a 5-FU-resistant cell line (RKO/R) and its parental cell line RKO/P were isolated and co-cultured with 5-FU-sensitive cells. Real-time cellular analysis (RTCA) and FACS analysis were used to examine cell viability and apoptosis. Exosomal protein profiling was performed using shotgun proteomics. Inhibitors and siRNAs were applied to study the involvement of selected proteins in 5-FU resistance. The effect of exosomal p-STAT3 (Tyr705) on the caspase cascade was examined by western blotting (WB) and high content analysis. Xenograft models were established to determine whether exosomal p-STAT3 can induce 5-FU resistance in vivo. Results Our results indicated that exosomes from RKO/R cells significantly promoted cell survival during 5-FU treatment. Proteomics and WB analysis results indicated that GSTP1 and p-STAT3 (Tyr705) were enriched in exosomes from RKO/R cells. Inhibition of p-STAT3 re-sensitized RKO/P cells to 5-FU via caspase cascade. Furthermore, p-STAT3 packaged by exosomes from RKO/R cells increased resistance of tumor cells to 5-FU in vivo. Conclusions Our results reveal a novel mechanism by which p-STAT3-containing exosomes contribute to acquired 5-FU resistance in CRC. This study suggests a new option for potentiating the 5-FU response and finding biomarkers for chemotherapy resistance. Electronic supplementary material The online version of this article (10.1186/s13046-019-1314-9) contains supplementary material, which is available to authorized users.

Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression

“…Studies have shown that up to 25% of CRC patients have distant metastasis at diagnosis and that the median overall survival (OS) of patients with mCRC is 28 months [28]. Although surgery combined with chemoradiotherapy can prolong the lifespan and alleviate the pain associated with the disease, mCRC patient prognosis remains poor.…”

GW4064 Enhances the Chemosensitivity of Colorectal Cancer to Oxaliplatin by Inducing Pyroptosis

“…Additionally, our results indicated that GW4064 could act cooperatively with oxaliplatin to inhibit STAT3 and subsequently regulate downstream targets to induce tumor cell apoptosis and pyroptosis. Excessive STAT3 activation in CRC is an important signaling mechanism that mediates tumor progression and drug resistance to chemotherapies (43). Blocking STAT3 signaling has been demonstrated to restore drug sensitivity in CRC (39).…”

Targeting STAT3 in Cancer Immunotherapy

“…Intriguingly, it has recently been shown that phosphorylated STAT3 is present in exosomes from 5-fluorouracil (5-FU) resistant colorectal cancer cells, which contributes to acquired 5-FU resistance [ 149 ]. Given the importance and efficiency of exosomes in intercellular and interorgan communication [ 150 , 151 ], these findings not only add another complexity to STAT3 regulation, but also pave a new way to inhibit the oncogenic function of STAT3, as well as to delivery STAT3 inhibitors via exosomes.…”